BleedingNCT00182117
Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population
An observational study of Bleeding and End Stage Renal Disease, run by Hamilton Health Sciences Corporation at 1 site in Canada.
Trial summary
This study is examining the risk and protective factors associated with bleeding in the hemodialysis population. Read more about this study
- Who is it for?
- Ages 0 years and older
- Conditions the study is for
- Bleeding, End Stage Renal Disease
- How many people
- 490 participants
- Where
- 1 siteCanada
- Study dates
- Oct 2003to Apr 2006
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 0 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Patient is undergoing hemodialysis
Who cannot join
- This is an observational study. No exclusion criteria required.
Trial locations and contacts
1 site in 1 country.
Canada1 site, 1 recruiting
- Recruiting
St. Joseph's Healthcare
Hamilton, Ontario, L8N 4A6
Christian G Rabbat, MD, 905-522-1155 ext. 6094, rabbatc@mcmaster.ca
Catherine M Clase, MD, 905-522-1155 ext. 6094, clase@mcmaster.ca
About this study
Official title: Pilot Bleeding Study
This study is examining the risk and protective factors associated with bleeding in the hemodialysis population.
- Conditions
- Bleeding, End Stage Renal Disease
- Keywords
- bleeding, end stage renal disease, antiplatelet therapy, anticoagulant therapy, hemodialysis
- Medical subject headings
- Hemorrhage, Kidney Failure, Chronic
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2005 (estimated)
- Study startOct 2003
- Study completionApr 2006
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for BleedingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Defined population
- Time perspective
- Retrospective
- Enrolment
- 490 participants
Sponsor and investigators
- Lead sponsor
- Hamilton Health Sciences Corporation
- Sponsor type
- University, hospital or other
- Collaborators
- St. Joseph's Healthcare Hamilton
- Investigators
- Christian G Rabbat, MD, Principal investigator, Assistant Professor, Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00182117
- Sponsor's protocol ID
- Division of Nephrology Funds
- Status last verified
- Sep 2005
- First submitted
- 9 Sep 2005
- Last updated
- 24 Jan 2006
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Jan 2006. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pilot Bleeding Study
- ClinicalTrials.gov ID
- NCT00182117
- Acronym / sponsor ID
- Division of Nephrology Funds
- Conditions
- Bleeding, End Stage Renal Disease
- Keywords
- bleeding, end stage renal disease, antiplatelet therapy, anticoagulant therapy, hemodialysis
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 490 participants
- Lead sponsor
- Hamilton Health Sciences CorporationUniversity, hospital or other
- Collaborators
- St. Joseph's Healthcare Hamilton
- Study start
- Oct 2003
- Study completion
- Apr 2006
- First posted
- 16 Sep 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is examining the risk and protective factors associated with bleeding in the hemodialysis population.
Study design
- Observational model
- Defined population
- Time perspective
- Retrospective
Who may qualify
- Ages
- 0 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Patient is undergoing hemodialysis
Key exclusion criteria (1 listed)
- This is an observational study. No exclusion criteria required.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Jan 2006.
Related trials for Bleeding
RecruitingPhase 1/2
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Hereditary Hemorrhagic Telangiectasia (HHT), Osler Weber Rendu Disease
Recruiting
The Psychological Effects of Miscarriage Prediction Score: A Prospective Study
Early Pregnancy Bleeding
Enrolling by invitation
Early Outcome of Simultaneous Bilateral Total Knee Replacement With and Without Tourniquet
Arthroplasty, Replacement, Knee, Blood Loss, Surgical
Not yet recruitingPhase 1
Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias
Immune Thrombocytopenia (ITP)
Active, not recruitingObservational study
Resumption of Anticoagulation After Major Gastrointestinal Bleeding in Patients With Atrial Fibrillation
Atrial Fibrillation (AF), Gastrointestinal Bleeding
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Christian G Rabbat, MD principal investigator
Assistant Professor, Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Bleeding and End Stage Renal Disease, run by Hamilton Health Sciences Corporation at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 24 Jan 2006. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Christian G Rabbat, MD (905-522-1155 ext. 3542, rabbatc@mcmaster.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jan 2006.